NEWS & EVENTS

2019 NHLBI Martha Vaughan, M.D., Symposium: Remembering Her Legacy

September 9 - 10 , 2019
NIH Campus - Lipsett Auditorium (Bldg 10)

Description

The National Heart, Lung and Blood Institute (NHLBI) invites you to attend the 2019 Martha Vaughan, M.D. Symposium: Remembering Her Legacy, which will bring together world experts on topics related to Dr. Vaughan’s areas of research interest and of the interests of her former post-doctoral fellows and other trainees. Dr. Vaughan also had a long-standing interest in mentoring and invitees will discuss how her mentoring affected their scientific and personal development.

The meeting will occur over two days on the NIH Bethesda campus and will include a dynamic range of invited speakers with clinical and scientific expertise. The meeting will begin at 9:00 am on September 9, 2019 and conclude by 2:30 pm on September 10, 2019. Please visit the event website to register!

Agenda

8:30-9:00 AM
-
Registration

8:55-9:00 AM
-
Introductions and Welcome

Joel Moss, M.D., Ph.D. (5 mins)
Senior Investigator, National Heart, Lung, and Blood Institute, NIH

9:00-9:10 AM
-
Opening Remarks

Gary Gibbons, M.D. (10 mins)
Director, National Heart, Lung, and Blood Institute, NIH

9:10-9:15 AM
-
Opening Remarks

Edward Korn, Ph.D. (5 mins)
Senior Investigator, National Heart, Lung, and Blood Institute, NIH

9:15-11:05 AM
-
Session 1: Mentoring and Human Rights
Moderator: Robert Balaban, Ph.D.

9:15-9:40 AM Mentoring in Career Development
Ferid Murad, M.D., Ph.D
Stanford University

9:40-10:05 AM Martha Vaughan and Human Rights
Michael Katz, M.D
Stanford University

10:05-10:30 AM Martha Vaughan: An NIH Pioneer
Michael Gottesman, M.D.
Office Intramural Research, NIH

10:30-10:55 AM Appreciation of Martha Vaughan
Toshiya Hirayama, Ph.D.
Nagasaki University, Japan

10:55-11:05 AM Coffee Break (10 mins)

11:05 AM - 3:30 PM
-
Session 2: Cell Structure and Signaling
Moderators: Paola Bruni, Ph.D. & Clare Waterman, Ph.D.

11:05-11:30 AM Sophisticated regulation of Arl1 activity at the Golgi complex
Fang-Jen Scott Lee, Ph.D.
National Taiwan University, Taiwan

11:30-11:55 PM Phospholipase D generated phosphatidic acid in membrane trafficking: lessons from phagocytosis and regulated exocytosis
Nicolas Vitale, Ph.D.
Institute for Cellular and Integrative Neurosciences, University of Strasbourg, Canada

11:55-12:20 PM MicroRNAs, chronic diseases and muscle-kidney crosstalk
S. Russ Price, Ph.D.
East Carolina University

12:20–1:15 PM Lunch

1:15–1:40 PM Integrating actin dynamics and adhesion in cell migration
Clare Waterman, Ph.D.
National Heart, Lung, and Blood Institute, NIH

1:40-2:05 PM Fatty acid activating enzyme ACSVL3 sustains the malignant phenotype in glioblastoma
Paul Watkins, M.D., Ph.D.
Johns Hopkins University School of Medicine

2:05-2:30 PM Sphingosine 1-phosphate signaling: its role in skeletal muscle precursor cell
Paola Bruni, Ph.D.
University of Florence, Italy

2:30-2:55 PM Ectodomain protein shedding by ADAM proteases in breast cancer
Anna Zolkiewska, Ph.D.
Kansas State University

2:55-3:20 PM Regulation by oxidation and reduction of protein methionine
Rodney Levine, M.D., Ph.D.
National Heart, Lung, and Blood Institute, NIH

3:20-3:30 PM Break (10 mins)

3:30-5:15 PM
-
Session 3: Infectious Diseases
Moderators: Drusilla Burns, Ph.D. & Kim Williamson, Ph.D.

3:30-3:55 PM Malaria transmission: from bench to field and back
Kim Williamson, Ph.D.
Uniformed Services University of the Health Sciences

3:55-4:20 PM Bacterial toxins: from basic research to vaccines
Drusilla Burns, Ph.D.
Food and Drug Administration (FDA)

4:20-4:45 PM Analysis of host response to subtilase cytotoxin produced by LEE-negative Enterohemorrhagic Escherichia coli
Kinnosuke Yahiro, Ph.D.
Chiba University, Japan

4:45-5:10 PM Next generation vaccines against botulism
Joseph T Barbieri, Ph.D.
Medical College of Wisconsin

5:15 PM Adjourn

8:30-9:00 AM
-
Registration

9:00-9:05 AM
-
Welcome and Opening Remarks

Rear Admiral Richard Childs, M.D. (5 mins)
Clinical Director, National Heart, Lung, and Blood Institute, NIH

9:05 AM - 2:15 PM
-
Session 4: Translational Studies in Lung Disease
Moderators: Kenneth Olivier, M.D. & Paola Rogliani, M.D.

9:05-9:30 AM Martha Vaughan, G-protein signaling and lymphangioleiomyomatosis
Arnold Kristof, M.D.C.M., F.R.C.P.C.
McGill University

9:30-9:55 AM Lymphatics in allograft rejection
Souheil El-Chemaly, M.D.
Harvard Medical School

9:55-10:20 AM Rare lung disease in China
Kai-Feng Xu, M.D.
Peking Union Medical College

10:20-10:45 AM A syndrome of idiopathic bronchiectasis and environmental mycobacteria – unraveling host susceptibility
Kenneth Olivier, M.D., M.P.H.
National Heart, Lung, and Blood Institute, NIH

10:45-11:10 AM Emerging roles of apolipoproteins in the pathogenesis and treatment of asthma
Stewart Levine, M.D.
National Heart, Lung, and Blood Institute, NIH

11:10-12:05 PM Lunch

12:05-12:30 AM Obstructive pulmonary disease and glucose metabolism: is there a real link?
Paola Rogliani, Ph.D.
University of Rome, Italy

12:30-12:55 PM Pathophysiology of LAM
Angelo Taveira-DaSilva, M.D., Ph.D.
National Heart, Lung, and Blood Institute, NIH

12:55-1:20 PM PH and ILD: where are we headed?
Sergio Harari, M.D.
San Giuseppe Hospital, Italy

1:20-1:45 PM Hermanksy-Pudlak Syndrome: A model Identify Mechanisms of Fibrosis
Bernadette Gochuico, M.D.
National Human Genome Research Institute (NHGRI), NIH

1:45-2:10 PM New insights into the pathogenesis of severe pulmonary fibrosis
Paul Noble, M.D.
Cedars-Sinai Medical Center in Los Angeles

2:10-2:15 PM Closing Remarks
Joel Moss, M.D., Ph.D. (5 mins)
National Heart, Lung, and Blood Institute, NIH

2:15 PM Adjourn